Montrose Environmental Group Selected by US Air Force as One of Top Environmental Firms for $1.5 Billion MATOC Contract
LITTLE ROCK, Ark., March 3, 2025 /PRNewswire/ -- Montrose Environmental Group (NYSE: MEG) is on a mission to help protect the air we breathe, the water we drink, and the soil that feeds us. The company has been selected as one of the top environmental firms by the United States Air Force for the Multiple Award Task Order Contract (MATOC). Under this contract, Montrose, in partnership with Tanaq Environmental —an Alaska Native Corporation and small, disadvantaged business—will work on various projects at Air Force installations worldwide over the next decade. The $1.5 billion MATOC contract includes projects that address environmental remediation of traditional and emerging contaminants, such as PFAS, and environmental planning and support services.
'We are honored to be selected by the United States Air Force to help safeguard the environment that supports those who protect us,' said Vijay Manthripragada, President and CEO of Montrose Environmental Solutions, Inc. 'Our deep expertise combined with industry-leading innovations deliver real-world impact and help us tackle some of the world's most pressing environmental challenges.'
Several firms, including Montrose, were selected for the contract with Montrose expected to receive a portion of the total $1.5 billion contract value. Since the Air Force has not yet initiated purchase orders, no financial impact is anticipated in 2025, and the contract is not reflected in Montrose's 2025 financial guidance provided on February 26, 2025.
Montrose Environmental Group is a leader in environmental solutions, delivering advanced, science-driven approaches to solve complex challenges, including emerging contaminants treatment, waste management, emissions, risk mitigation and regulatory demands. With a strong portfolio of patented technologies and ongoing research and development, we provide best-in-class remediation, testing, and compliance solutions that help industries and governments proactively address environmental risks. Our expertise spans the public sector, including projects with the Environmental Protection Agency (EPA), the Department of Defense, and state environmental agencies, reinforcing our trusted partnership in safeguarding public health.
Montrose is committed to enabling economic progress while advancing environmental stewardship. We deliver scalable, cost-effective solutions that protect communities, ensure regulatory compliance, and drive sustainable outcomes. Learn more about our solutions for the Federal sector.
About Montrose
Montrose is a leading environmental solutions company focused on supporting commercial and government organizations as they deal with the challenges of today and prepare for what's coming tomorrow. With ~3,400 employees across 100+ locations worldwide, Montrose combines deep local knowledge with an integrated approach to design, engineering, and operations, enabling Montrose to respond effectively and efficiently to the unique requirements of each project. From comprehensive air measurement and laboratory services to regulatory compliance, emergency response, permitting, engineering, and remediation, Montrose delivers innovative and practical solutions that keep its clients on top of their immediate needs – and well ahead of the strategic curve. For more information, visit www.montrose-env.com. Follow us on LinkedIn.
Forward–Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may be identified by the use of words such as 'intend,' 'expect', and 'may', and other similar expressions that predict or indicate future events or that are not statements of historical matters. Forward-looking statements are based on current information available at the time the statements are made and on management's reasonable belief or expectations with respect to future events, and are subject to risks and uncertainties, many of which are beyond the Company's control, that could cause actual performance or results to differ materially from the belief or expectations expressed in or suggested by the forward-looking statements. Additional factors or events that could cause actual results to differ may also emerge from time to time, and it is not possible for the Company to predict all of them. Forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update any forward-looking statement to reflect future events, developments or otherwise, except as may be required by applicable law. Investors are referred to the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2023, for additional information regarding the risks and uncertainties that may cause actual results to differ materially from those expressed in any forward-looking statement.
Contacts
Media Relations
Tammy Hovey
SOURCE Montrose Environmental Group, Inc.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Merck & Co., Inc. (MRK) Announces Update on Phase 3 KEYNOTE-905 Trial
Merck & Co., Inc. (NYSE:MRK) is included in our list of the . A dose bottle of the medication is in the medical tech's hand On August 12, 2025, Merck & Co., Inc. (NYSE:MRK) announced an update regarding its Phase 3 KEYNOTE-905 trial. According to the update, the trial met its primary and key secondary endpoints in patients with muscle-invasive bladder cancer (MIBC) who are ineligible for cisplatin-based chemotherapy. The study revealed improved event-free survival, overall survival, and pathologic complete response rates compared to surgery alone. The improved outcome was a result of giving patients KEYTRUDA (pembrolizumab) and Padcev (enfortumab vedotin-ejfv) medicines before and after surgery. The trial, carried out in collaboration with Pfizer and Astellas, marks the first systemic treatment that enhances survival rates in this patient group. Furthermore, no new side effects were observed. Operating through its Pharmaceutical and Animal Health segments, Merck & Co., Inc. (NYSE:MRK) leads as a healthcare company worldwide. It is included in our list of the most undervalued value stocks to buy. While we acknowledge the potential of MRK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Best Oil Refinery Stocks to Buy Right Now and 7 Best Potash Stocks to Buy According to Analysts. Disclosure: None.


Business Wire
an hour ago
- Business Wire
Corpay Cross-Border 成為 New Zealand Football 官方外匯合作夥伴
多倫多--(BUSINESS WIRE)--(美國商業資訊)-- Corpay, Inc.* (紐約證券交易所代碼:CPAY) 作為全球企業支付領域的領導者,欣然宣佈旗下 Corpay Cross-Border 業務已與 New Zealand Football 簽署協議,成為其官方外匯合作(FX)夥伴。 透過這項合作,New Zealand Football 將能運用 Corpay Cross-Border 的創新解決方案,協助降低日常營運中的外匯風險。此外,Corpay Cross-Border 屢獲殊榮的平台,亦將使其能夠透過單一入口管理全球支付。 「Corpay Cross-Border 謹此恭賀 New Zealand Football 及 All Whites 成功取得 2026 FIFA 世界盃的參賽資格。」Corpay Cross-Border Solutions 首席市場營銷官 Brad Loder 表示,「我們高度重視 Corpay 品牌的發展,以及在紐西蘭的企業支付及外匯風險管理業務。作為官方外匯合作夥伴,我們期待與 New Zealand Football 攜手備戰世界盃,並建立長期合作關係。」 「隨着我們機構的發展與成熟,需要持續檢視國際營運的方式。此次與大型金融機構的合作,顯示我們已經站在全球化的思維層面。」New Zealand Football 行政總裁 Andrew Pragnell 表示,「能夠在紐西蘭足球運動蓬勃發展的時刻與 Corpay 合作,實在令人振奮,因為這項運動正在紐西蘭的各個層面持續壯大。」 關於Corpay Corpay, Inc. (NYSE: CPAY)是一家全球性標準普爾500指數企業支付公司,致力於協助企業和消費者以簡單、可控的方式支付費用。Corpay的現代支付解決方案套件協助其客戶更好地管理與車輛相關的費用(如加油和停車)、旅行費用(如酒店預訂)和應付帳款(如向供應商付款),從而讓我們的客戶能夠節省時間並最終減少支出。Corpay Cross-Border是指由Corpay, Inc.擁有和經營的一組法律實體。 Corpay——讓付款變得簡單。如欲瞭解更多資訊,請造訪: 。 *本文中的「Corpay」主要指Corpay, Inc.的跨境業務部門: ;查看Corpay跨境業務部門旗下公司的完整列表,請造訪: 。 免責聲明:本公告之原文版本乃官方授權版本。譯文僅供方便瞭解之用,煩請參照原文,原文版本乃唯一具法律效力之版本。
Yahoo
an hour ago
- Yahoo
BHP Group Ltd (BHP) (FY 2025) Earnings Call Highlights: Record Production and Strategic ...
This article first appeared on GuruFocus. Release Date: August 19, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points BHP Group Ltd (NYSE:BHP) achieved record iron ore and copper production, with copper volumes growing by 28% over the past three years. The company delivered a strong financial performance with an underlying EBITDA margin of 53% and a return on capital employed of 21%. BHP Group Ltd (NYSE:BHP) paid a final dividend of 60 US cents per share, resulting in a full-year dividend of $5.6 billion. The company achieved gender balance in its global workforce, with female representation now at 41.3%, contributing to better business performance. BHP Group Ltd (NYSE:BHP) has reduced its capital spend by $1 billion per year over the medium term and revised its target net debt range to $10 to $20 billion. Negative Points The company experienced a 10% decline in EBITDA due to unfavorable commodity prices, despite favorable foreign exchange rates. BHP Group Ltd (NYSE:BHP) encountered higher inflation and cost escalation than anticipated, particularly affecting the Jansen project. The pace of development for decarbonization technology has slowed, delaying anticipated operational decarbonization spend to the 2030s. Higher labor costs over and above CPI inflation impacted the company's financial performance. The transition to closure for New South Wales Energy Coal is progressing, indicating a phase-out of operations in that segment. Q & A Highlights Warning! GuruFocus has detected 5 Warning Sign with BHP. Is BHP fairly valued? Test your thesis with our free DCF calculator. Q: Can you elaborate on the factors contributing to the 10% decline in EBITDA? A: The decline in EBITDA was entirely due to commodity prices. While we benefited from favorable foreign exchange rates, these were offset by inflationary pressures. Despite this, our operational performance remained strong, with copper equivalent volume growth up around 4%. (CFO, Vendita Pant) Q: How has BHP managed to maintain its position as the lowest cost major iron ore producer globally? A: Western Australia iron ore has consistently demonstrated its leadership with record production and shipments, achieving an EBITDA margin of 63%. Our costs are just $17.29 per ton, maintaining our status as the lowest cost major iron ore producer for six consecutive years. (CFO, Vendita Pant) Q: What are the future growth projections for BHP's production? A: Assuming our projects proceed as planned, we anticipate an average production growth of 2.2% per annum over the next decade. This growth is supported by our focus on highly attractive commodities and world-class assets. (CEO, Mike Henry) Q: Can you discuss the impact of inflation and cost escalation on the Jansen project? A: We encountered higher inflation and cost escalation than anticipated, particularly in surface works. We've taken action to contain these costs and will apply learnings to future projects. The first production for stage 2 has been extended by two years to free up capital for higher returning projects. (CEO, Mike Henry) Q: How is BHP addressing the challenges in decarbonization technology development? A: The pace of development for our decarbonization technology, particularly diesel displacement, has slowed. We now expect operational decarbonization spending to occur in the 2030s, aligning with the delayed timeline for critical technologies. However, we remain on track to meet our 2030 target for operational greenhouse gas emissions. (CFO, Vendita Pant) For the complete transcript of the earnings call, please refer to the full earnings call transcript.